User Profile
/
Watchlists
/
Beat the Benchmark 2026 Portfolio - Possible list

Beat the Benchmark 2026 Portfolio - Possible list

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Clive_Thompson

172 followers99 views

Watching

Company	Price & Valuation	My FV & Narrative	Valuation	Growth	Analyst Target
ALHC Alignment Healthcare US$20.5617.5% undervalued intrinsic discount 44.3%7D 20.1%3M AN US$24.92author fair value 30 Mayauthor updated this narrative ALHC: Margin Recovery Will Drive Medicare Advantage Market Share Gains
8795 T&D Holdings JP¥4,686.004.0% overvalued intrinsic discount 10.8%7D 25.5%3M AN JP¥4.51kauthor fair value 02 Mayauthor updated this narrative Analysts Lift T&D Holdings Price Target as Revenue Outlook Improves Despite Lower Margins
HRMY Harmony Biosciences Holdings US$35.4825.0% undervalued intrinsic discount 10.5%7D 27.7%3M AN US$47.3author fair value 23 Febauthor updated this narrative Expanding Sleep And Rare Disease Markets Will Unlock Future Potential
NIC Nicolet Bankshares US$144.8316.9% undervalued intrinsic discount 9.8%7D -3.2%3M US$174.2author fair value 25 Julauthor updated this narrative Analysts are bullish with a Price Target of $174.20 based on 27.0% annual revenue growth forecasts.
ARGX argenx €763.009.7% undervalued intrinsic discount 9.7%7D 23.9%3M AN €845.01author fair value 14 Mayauthor updated this narrative ARGX: Upcoming Phase 3 Readouts and Expanded Access Will Shape Future Outlook
ADS adidas €172.1013.2% undervalued intrinsic discount 6.5%7D 21.9%3M AN €198.28author fair value 04 Junauthor updated this narrative ADS: Stable Profit Margins Will Support Renewed Confidence Amid Legal Scrutiny
RNST Renasant US$41.957.9% undervalued intrinsic discount 6.4%7D 16.3%3M AN US$45.57author fair value 01 Junauthor updated this narrative Southeastern Expansion And Merger Synergies Will Create Value
FITB Fifth Third Bancorp US$52.658.3% undervalued intrinsic discount 6.4%7D 20.8%3M AN US$57.42author fair value 06 Junauthor updated this narrative Analyst Commentary Highlights Optimism and Caution on Fifth Third Bancorp Amid Merger and Valuation Shifts
COLB Columbia Banking System US$30.325.5% undervalued intrinsic discount 6.1%7D 14.8%3M AN US$32.08author fair value 06 Junauthor updated this narrative COLB: Upgraded Ratings And Peer-Leading Returns Will Drive Outperformance
CAMX Camurus SEK 542.0029.6% undervalued intrinsic discount 5.8%7D 15.1%3M AN SEK 770.13author fair value 29 Aprauthor updated this narrative Global Expansion And Regulatory Approvals Will Transform Healthcare Delivery
SFNC Simmons First National US$21.956.9% undervalued intrinsic discount 5.3%7D 16.1%3M AN US$23.57author fair value 02 Junauthor updated this narrative Urbanization And Digital Adoption Will Transform US Banking
CCB Coastal Financial US$71.3232.9% undervalued intrinsic discount 5.2%7D -7.8%3M US$106.25author fair value 19 Junauthor updated this narrative Analysts are bullish with a Price Target of $106.25 based on 77.0% annual revenue growth forecasts.
MONY MONY Group UK£1.8633.5% undervalued intrinsic discount 5.1%7D 10.8%3M AN UK£2.8author fair value 04 Junauthor updated this narrative Rising Middle Class And AI Integration Will Expand Markets
BETS B Betsson SEK 91.8045.0% undervalued intrinsic discount 4.6%7D -7.6%3M IM SEK 167author fair value 04 Junauthor updated this narrative The Market Is Paying You a 9.3% Dividend and an 18.9% FCF Yield to Wait for a Recovery That's Already Starting
MRP Millrose Properties US$28.8025.4% undervalued intrinsic discount 4.6%7D 0.9%3M AN US$38.6author fair value 14 Decauthor updated this narrative Long-Term Housing Undersupply And AI Underwriting Will Support Strong Future Performance
966 China Taiping Insurance Holdings HK$20.7217.9% undervalued intrinsic discount 4.5%7D -4.6%3M HK$25.23author fair value 19 Junauthor updated this narrative Analysts are bullish with a Price Target of HK$25.23 based on 103.3% annual revenue growth forecasts.
CS AXA €40.5312.8% undervalued intrinsic discount 3.8%7D 6.3%3M AN €46.48author fair value 03 Junauthor updated this narrative CS: Rising Profit Margins And Multiples Will Drive Global Expansion
MRK Merck US$119.098.2% undervalued intrinsic discount 3.8%7D 2.7%3M AN US$129.74author fair value 01 Junauthor updated this narrative US Investments And New Product Launches Will Shape Future Markets
EVO Evolution SEK 723.008.6% overvalued intrinsic discount 3.7%7D 21.6%3M AN SEK 665.8author fair value 06 Junauthor updated this narrative Sector Downgrades And Digital Shifts Will Shape Near-Term Opportunities
MFC Manulife Financial CA$54.771.1% undervalued intrinsic discount 3.3%7D 19.9%3M AN CA$55.38author fair value 05 Junauthor updated this narrative MFC: Sector Headwinds And Mixed Performance Will Shape Near-Term Outlook
AGS ageas €65.101.5% overvalued intrinsic discount 2.1%7D 9.2%3M AN €64.11author fair value 12 Decauthor updated this narrative Asian Life Shift And Esure Integration Will Drive Stronger, More Resilient Earnings Ahead
939 China Construction Bank HK$8.755.8% undervalued intrinsic discount 2.1%7D 10.5%3M AN HK$9.29author fair value 20 Mayauthor updated this narrative Mounting Headwinds And Digital Shifts Will Suppress Future Margins
EXEL Exelixis US$52.585.9% overvalued intrinsic discount 1.9%7D 27.7%3M AN US$49.65author fair value 11 Junauthor updated this narrative Expanding Global Oncology Markets Will Broaden Patient Access
HBAN Huntington Bancshares US$16.8466.6% overvalued intrinsic discount 1.9%7D 10.7%3M MS US$10.11author fair value 27 Sepauthor updated this narrative Overvalued HBAN
9911 Newborn Town HK$8.1841.4% undervalued intrinsic discount 1.0%7D -24.0%3M HK$13.97author fair value 25 Julauthor updated this narrative Analysts are bullish with a Price Target of HK$13.97 based on 24.4% annual revenue growth forecasts.
4206 Aica Kogyo Company JP¥3,462.0014.5% undervalued intrinsic discount 0.8%7D -5.8%3M JP¥4.05kauthor fair value 25 Julauthor updated this narrative Analysts are bullish with a Price Target of ¥4,050 based on 10.5% annual revenue growth forecasts.
DKSH DKSH Holding CHF 62.7013.6% undervalued intrinsic discount -0.2%7D 4.7%3M AN CHF 72.57author fair value 11 Febauthor updated this narrative Asia Pacific Expansion And Digitalization Will Fuel Sustainable Success
RHM Rheinmetall €1,197.2036.6% undervalued intrinsic discount -0.3%7D -22.8%3M AN €1.89kauthor fair value 01 Junauthor updated this narrative Analysts Highlight Cautious Optimism Amid Valuation Gains and Strategic Shifts at Rheinmetall
PNFP Pinnacle Financial Partners US$93.1120.3% undervalued intrinsic discount -0.4%7D 11.4%3M AN US$116.79author fair value 05 Junauthor updated this narrative PNFP: Revenue Momentum And Pending Synovus Merger Will Drive Future Upside
MNSO MINISO Group Holding US$13.1736.4% undervalued intrinsic discount -0.8%7D -21.4%3M BE US$20.71author fair value 08 Junauthor updated this narrative MINISO's fair value is projected at 26.69 with an anticipated PE ratio shift of 20x
BAER Julius Bär Gruppe CHF 63.748.2% undervalued intrinsic discount -1.5%7D 5.0%3M AN CHF 69.41author fair value 02 Junauthor updated this narrative Digital Transformation And Global Wealth Transfers Will Empower Private Banking
COPN Cosmo CHF 70.5029.5% undervalued intrinsic discount -1.9%7D -21.9%3M KA CHF 100author fair value 16 Mayauthor updated this narrative Cosmo Pharmaceuticals Announces Strong Full Year 2024 Revenue and Cash and Provides Business and Pipeline Updates
4042 Tosoh JP¥2,771.006.3% undervalued intrinsic discount -2.7%7D 14.1%3M JP¥2.96kauthor fair value 19 Junauthor updated this narrative Analysts are neutral with a Price Target of ¥2,959 based on 7.5% annual revenue growth forecasts.
MELI MercadoLibre US$1,588.2930.5% undervalued intrinsic discount -3.1%7D -5.5%3M JO US$2.28kauthor fair value 20 Mayauthor updated this narrative MercadoLibre's 19% Revenue Growth Will Propel Their Future Success
2419 Dekon Food and Agriculture Group HK$49.7250.8% undervalued intrinsic discount -4.5%7D -36.4%3M HK$101.02author fair value 25 Julauthor updated this narrative Analysts are bullish with a Price Target of HK$101.02 based on 10.0% annual revenue growth forecasts.
HACK Hacksaw SEK 77.5522.3% undervalued intrinsic discount -4.5%7D 30.8%3M AN SEK 99.87author fair value 25 Janauthor updated this narrative Expanding Games Portfolio And New Regulated Markets Will Support Long Term Earnings Potential
TPC Tutor Perini US$68.7229.9% undervalued intrinsic discount -4.9%7D -0.7%3M AN US$98author fair value 03 Mayauthor updated this narrative Labor Shortages Will Hurt Margins Yet Spark Efficiency Gains
MLYS Mineralys Therapeutics US$23.7653.3% undervalued intrinsic discount -5.2%7D -12.0%3M AN US$50.88author fair value 05 Marauthor updated this narrative Hypertension And Cardiorenal Catalysts Will Reshape Long Term Prospects For This Biotech
ONC BeOne Medicines US$263.6135.9% undervalued intrinsic discount -5.5%7D -7.6%3M AN US$411.51author fair value 23 Mayauthor updated this narrative ONC: Pivotal Oncology Trial Data Will Drive Future Upside Momentum
BS6 Yangzijiang Shipbuilding (Holdings) S$3.3738.3% undervalued intrinsic discount -5.9%7D -16.0%3M KA S$5.46author fair value 04 Junauthor updated this narrative Yangzijiang Shipbuilding Aims for a 30% Profit Margin Boost
BDT Bird Construction CA$58.527.7% undervalued intrinsic discount -6.7%7D 78.2%3M AN CA$63.38author fair value 03 Junauthor updated this narrative Sustained Sector Optimism And Major Project Wins Will Support Long-Term Expansion
999 Xiaocaiyuan International Holding HK$6.8025.0% undervalued intrinsic discount -7.0%7D -13.7%3M HK$9.06author fair value 19 Decauthor updated this narrative Analysts are bullish with a Price Target of HK$9.06 based on 3.8% annual revenue growth forecasts.
LKNC.Y Luckin Coffee US$30.3033.5% undervalued intrinsic discount -7.0%7D -12.3%3M AN US$45.58author fair value 05 Junauthor updated this narrative Chinese Urbanization And Digital Transformation Will Unlock Market Potential
AGI Alamos Gold CA$45.9644.8% undervalued intrinsic discount -12.4%7D -30.5%3M AN CA$83.26author fair value 05 Junauthor updated this narrative Analysts Lift Alamos Gold Price Target Amid Strong Growth Improved Margins and Positive Outlook
AU AngloGold Ashanti US$78.4736.4% undervalued intrinsic discount -12.7%7D -25.1%3M AN US$123.29author fair value 28 Mayauthor updated this narrative AU: Strengthening Margins And Revenue Will Drive Upward Momentum In Coming Years
EMR Emerald Resources AU$5.0937.4% undervalued intrinsic discount -16.3%7D -15.0%3M AU$8.13author fair value 19 Junauthor updated this narrative Analysts are bullish with a Price Target of A$8.13 based on 65.4% annual revenue growth forecasts.
RUSTA Rusta SEK 71.8526.3% undervalued intrinsic discount -19.3%7D -18.9%3M AN SEK 97.5author fair value 03 Junauthor updated this narrative Upcoming Store Expansion And Supply Chain Investments Will Increase Future Market Reach

Watching

Company	Price & Valuation	My FV & Narrative	Valuation	Growth	Analyst Target
ALHC Alignment Healthcare 44.3%7D 20.1%3M	US$20.56 17.5% undervalued intrinsic discount	AN US$24.92author fair value 30 Mayauthor updated this narrative ALHC: Margin Recovery Will Drive Medicare Advantage Market Share Gains	PS 1x	E 39.5%	US$24.92
8795 T&D Holdings 10.8%7D 25.5%3M	JP¥4,686.00 4.0% overvalued intrinsic discount	AN JP¥4.51kauthor fair value 02 Mayauthor updated this narrative Analysts Lift T&D Holdings Price Target as Revenue Outlook Improves Despite Lower Margins	PE 16.2x	E 6.4%	JP¥4,651.11
HRMY Harmony Biosciences Holdings 10.5%7D 27.7%3M	US$35.48 25.0% undervalued intrinsic discount	AN US$47.3author fair value 23 Febauthor updated this narrative Expanding Sleep And Rare Disease Markets Will Unlock Future Potential	PE 14.1x	E 18.2%	US$44.36
NIC Nicolet Bankshares 9.8%7D -3.2%3M	US$144.83 16.9% undervalued intrinsic discount	US$174.2author fair value 25 Julauthor updated this narrative Analysts are bullish with a Price Target of $174.20 based on 27.0% annual revenue growth forecasts.	PE 23.1x	E 40.5%	US$174.20
ARGX argenx 9.7%7D 23.9%3M	€763.00 9.7% undervalued intrinsic discount	AN €845.01author fair value 14 Mayauthor updated this narrative ARGX: Upcoming Phase 3 Readouts and Expanded Access Will Shape Future Outlook	PE 36.8x	E 21.7%	€846.68
ADS adidas 6.5%7D 21.9%3M	€172.10 13.2% undervalued intrinsic discount	AN €198.28author fair value 04 Junauthor updated this narrative ADS: Stable Profit Margins Will Support Renewed Confidence Amid Legal Scrutiny	PE 21.9x	E 14.7%	€199.71
RNST Renasant 6.4%7D 16.3%3M	US$41.95 7.9% undervalued intrinsic discount	AN US$45.57author fair value 01 Junauthor updated this narrative Southeastern Expansion And Merger Synergies Will Create Value	PE 17x	E 22.6%	US$45.57
FITB Fifth Third Bancorp 6.4%7D 20.8%3M	US$52.65 8.3% undervalued intrinsic discount	AN US$57.42author fair value 06 Junauthor updated this narrative Analyst Commentary Highlights Optimism and Caution on Fifth Third Bancorp Amid Merger and Valuation Shifts	PE 23.6x	E 22.3%	US$57.52
COLB Columbia Banking System 6.1%7D 14.8%3M	US$30.32 5.5% undervalued intrinsic discount	AN US$32.08author fair value 06 Junauthor updated this narrative COLB: Upgraded Ratings And Peer-Leading Returns Will Drive Outperformance	PE 13.4x	E 17.5%	US$32.08
CAMX Camurus 5.8%7D 15.1%3M	SEK 542.00 29.6% undervalued intrinsic discount	AN SEK 770.13author fair value 29 Aprauthor updated this narrative Global Expansion And Regulatory Approvals Will Transform Healthcare Delivery	PE 47.5x	E 35.0%	SEK 771.38
SFNC Simmons First National 5.3%7D 16.1%3M	US$21.95 6.9% undervalued intrinsic discount	AN US$23.57author fair value 02 Junauthor updated this narrative Urbanization And Digital Adoption Will Transform US Banking	PB 0.9x	E 112.8%	US$23.57
CCB Coastal Financial 5.2%7D -7.8%3M	US$71.32 32.9% undervalued intrinsic discount	US$106.25author fair value 19 Junauthor updated this narrative Analysts are bullish with a Price Target of $106.25 based on 77.0% annual revenue growth forecasts.	PE 22.1x	E 45.5%	US$106.25
MONY MONY Group 5.1%7D 10.8%3M	UK£1.86 33.5% undervalued intrinsic discount	AN UK£2.8author fair value 04 Junauthor updated this narrative Rising Middle Class And AI Integration Will Expand Markets	PE 11.8x	E 7.0%	UK£2.28
BETS B Betsson 4.6%7D -7.6%3M	SEK 91.80 45.0% undervalued intrinsic discount	IM SEK 167author fair value 04 Junauthor updated this narrative The Market Is Paying You a 9.3% Dividend and an 18.9% FCF Yield to Wait for a Recovery That's Already Starting	PE 7.3x	E -1.3%	SEK 103.33
MRP Millrose Properties 4.6%7D 0.9%3M	US$28.80 25.4% undervalued intrinsic discount	AN US$38.6author fair value 14 Decauthor updated this narrative Long-Term Housing Undersupply And AI Underwriting Will Support Strong Future Performance	PE 10.3x	E 5.5%	US$37.60
966 China Taiping Insurance Holdings 4.5%7D -4.6%3M	HK$20.72 17.9% undervalued intrinsic discount	HK$25.23author fair value 19 Junauthor updated this narrative Analysts are bullish with a Price Target of HK$25.23 based on 103.3% annual revenue growth forecasts.	PE 2.9x	E -17.3%	HK$25.23
CS AXA 3.8%7D 6.3%3M	€40.53 12.8% undervalued intrinsic discount	AN €46.48author fair value 03 Junauthor updated this narrative CS: Rising Profit Margins And Multiples Will Drive Global Expansion	PE 11.5x	E 6.7%	€46.48
MRK Merck 3.8%7D 2.7%3M	US$119.09 8.2% undervalued intrinsic discount	AN US$129.74author fair value 01 Junauthor updated this narrative US Investments And New Product Launches Will Shape Future Markets	PE 32.9x	E 21.2%	US$129.74
EVO Evolution 3.7%7D 21.6%3M	SEK 723.00 8.6% overvalued intrinsic discount	AN SEK 665.8author fair value 06 Junauthor updated this narrative Sector Downgrades And Digital Shifts Will Shape Near-Term Opportunities	PE 12.4x	E 4.3%	SEK 665.80
MFC Manulife Financial 3.3%7D 19.9%3M	CA$54.77 1.1% undervalued intrinsic discount	AN CA$55.38author fair value 05 Junauthor updated this narrative MFC: Sector Headwinds And Mixed Performance Will Shape Near-Term Outlook	PE 15.5x	E 10.2%	CA$55.38
AGS ageas 2.1%7D 9.2%3M	€65.10 1.5% overvalued intrinsic discount	AN €64.11author fair value 12 Decauthor updated this narrative Asian Life Shift And Esure Integration Will Drive Stronger, More Resilient Earnings Ahead	PE 7.3x	E 0.2%	€67.45
939 China Construction Bank 2.1%7D 10.5%3M	HK$8.75 5.8% undervalued intrinsic discount	AN HK$9.29author fair value 20 Mayauthor updated this narrative Mounting Headwinds And Digital Shifts Will Suppress Future Margins	PE 5.9x	E 5.4%	HK$10.73
EXEL Exelixis 1.9%7D 27.7%3M	US$52.58 5.9% overvalued intrinsic discount	AN US$49.65author fair value 11 Junauthor updated this narrative Expanding Global Oncology Markets Will Broaden Patient Access	PE 15.9x	E 11.9%	US$49.65
HBAN Huntington Bancshares 1.9%7D 10.7%3M	US$16.84 66.6% overvalued intrinsic discount	MS US$10.11author fair value 27 Sepauthor updated this narrative Overvalued HBAN	PE 16.5x	E 16.1%	US$19.84
9911 Newborn Town 1.0%7D -24.0%3M	HK$8.18 41.4% undervalued intrinsic discount	HK$13.97author fair value 25 Julauthor updated this narrative Analysts are bullish with a Price Target of HK$13.97 based on 24.4% annual revenue growth forecasts.	PE 10.7x	E 16.7%	HK$13.97
4206 Aica Kogyo Company 0.8%7D -5.8%3M	JP¥3,462.00 14.5% undervalued intrinsic discount	JP¥4.05kauthor fair value 25 Julauthor updated this narrative Analysts are bullish with a Price Target of ¥4,050 based on 10.5% annual revenue growth forecasts.	PE 11.8x	E 5.1%	JP¥4,050.00
DKSH DKSH Holding -0.2%7D 4.7%3M	CHF 62.70 13.6% undervalued intrinsic discount	AN CHF 72.57author fair value 11 Febauthor updated this narrative Asia Pacific Expansion And Digitalization Will Fuel Sustainable Success	PE 20.1x	E 9.4%	CHF 73.93
RHM Rheinmetall -0.3%7D -22.8%3M	€1,197.20 36.6% undervalued intrinsic discount	AN €1.89kauthor fair value 01 Junauthor updated this narrative Analysts Highlight Cautious Optimism Amid Valuation Gains and Strategic Shifts at Rheinmetall	PE 53.1x	E 30.8%	€1,889.38
PNFP Pinnacle Financial Partners -0.4%7D 11.4%3M	US$93.11 20.3% undervalued intrinsic discount	AN US$116.79author fair value 05 Junauthor updated this narrative PNFP: Revenue Momentum And Pending Synovus Merger Will Drive Future Upside	PE 22.4x	E 51.1%	US$116.53
MNSO MINISO Group Holding -0.8%7D -21.4%3M	US$13.17 36.4% undervalued intrinsic discount	BE US$20.71author fair value 08 Junauthor updated this narrative MINISO's fair value is projected at 26.69 with an anticipated PE ratio shift of 20x	PE 13.3x	E 19.6%	US$20.76
BAER Julius Bär Gruppe -1.5%7D 5.0%3M	CHF 63.74 8.2% undervalued intrinsic discount	AN CHF 69.41author fair value 02 Junauthor updated this narrative Digital Transformation And Global Wealth Transfers Will Empower Private Banking	PE 17.1x	E 13.6%	CHF 69.35
COPN Cosmo -1.9%7D -21.9%3M	CHF 70.50 29.5% undervalued intrinsic discount	KA CHF 100author fair value 16 Mayauthor updated this narrative Cosmo Pharmaceuticals Announces Strong Full Year 2024 Revenue and Cash and Provides Business and Pipeline Updates	PS 11.9x	E 42.0%	CHF 128.38
4042 Tosoh -2.7%7D 14.1%3M	JP¥2,771.00 6.3% undervalued intrinsic discount	JP¥2.96kauthor fair value 19 Junauthor updated this narrative Analysts are neutral with a Price Target of ¥2,959 based on 7.5% annual revenue growth forecasts.	PE 20.5x	E 14.1%	JP¥2,958.89
MELI MercadoLibre -3.1%7D -5.5%3M	US$1,588.29 30.5% undervalued intrinsic discount	JO US$2.28kauthor fair value 20 Mayauthor updated this narrative MercadoLibre's 19% Revenue Growth Will Propel Their Future Success	PE 41.9x	E 26.9%	US$2,216.96
2419 Dekon Food and Agriculture Group -4.5%7D -36.4%3M	HK$49.72 50.8% undervalued intrinsic discount	HK$101.02author fair value 25 Julauthor updated this narrative Analysts are bullish with a Price Target of HK$101.02 based on 10.0% annual revenue growth forecasts.	PE 11.6x	E 51.4%	HK$101.02
HACK Hacksaw -4.5%7D 30.8%3M	SEK 77.55 22.3% undervalued intrinsic discount	AN SEK 99.87author fair value 25 Janauthor updated this narrative Expanding Games Portfolio And New Regulated Markets Will Support Long Term Earnings Potential	PE 13.2x	E 24.8%	SEK 103.49
TPC Tutor Perini -4.9%7D -0.7%3M	US$68.72 29.9% undervalued intrinsic discount	AN US$98author fair value 03 Mayauthor updated this narrative Labor Shortages Will Hurt Margins Yet Spark Efficiency Gains	PE 46.3x	E 49.6%	US$113.25
MLYS Mineralys Therapeutics -5.2%7D -12.0%3M	US$23.76 53.3% undervalued intrinsic discount	AN US$50.88author fair value 05 Marauthor updated this narrative Hypertension And Cardiorenal Catalysts Will Reshape Long Term Prospects For This Biotech	PB 3.1x	E 56.8%	US$49.00
ONC BeOne Medicines -5.5%7D -7.6%3M	US$263.61 35.9% undervalued intrinsic discount	AN US$411.51author fair value 23 Mayauthor updated this narrative ONC: Pivotal Oncology Trial Data Will Drive Future Upside Momentum	PE 57.1x	E 29.0%	US$412.35
BS6 Yangzijiang Shipbuilding (Holdings) -5.9%7D -16.0%3M	S$3.37 38.3% undervalued intrinsic discount	KA S$5.46author fair value 04 Junauthor updated this narrative Yangzijiang Shipbuilding Aims for a 30% Profit Margin Boost	PE 8.1x	E 9.3%	S$4.42
BDT Bird Construction -6.7%7D 78.2%3M	CA$58.52 7.7% undervalued intrinsic discount	AN CA$63.38author fair value 03 Junauthor updated this narrative Sustained Sector Optimism And Major Project Wins Will Support Long-Term Expansion	PE 65.6x	E 49.2%	CA$63.38
999 Xiaocaiyuan International Holding -7.0%7D -13.7%3M	HK$6.80 25.0% undervalued intrinsic discount	HK$9.06author fair value 19 Decauthor updated this narrative Analysts are bullish with a Price Target of HK$9.06 based on 3.8% annual revenue growth forecasts.	PE 9.7x	E 6.8%	HK$9.06
LKNC.Y Luckin Coffee -7.0%7D -12.3%3M	US$30.30 33.5% undervalued intrinsic discount	AN US$45.58author fair value 05 Junauthor updated this narrative Chinese Urbanization And Digital Transformation Will Unlock Market Potential	PE 18.5x	E 22.2%	US$45.40
AGI Alamos Gold -12.4%7D -30.5%3M	CA$45.96 44.8% undervalued intrinsic discount	AN CA$83.26author fair value 05 Junauthor updated this narrative Analysts Lift Alamos Gold Price Target Amid Strong Growth Improved Margins and Positive Outlook	PE 13x	E 17.9%	CA$83.26
AU AngloGold Ashanti -12.7%7D -25.1%3M	US$78.47 36.4% undervalued intrinsic discount	AN US$123.29author fair value 28 Mayauthor updated this narrative AU: Strengthening Margins And Revenue Will Drive Upward Momentum In Coming Years	PE 11.4x	E 10.6%	US$121.29
EMR Emerald Resources -16.3%7D -15.0%3M	AU$5.09 37.4% undervalued intrinsic discount	AU$8.13author fair value 19 Junauthor updated this narrative Analysts are bullish with a Price Target of A$8.13 based on 65.4% annual revenue growth forecasts.	PE 33.3x	E 51.6%	AU$8.13
RUSTA Rusta -19.3%7D -18.9%3M	SEK 71.85 26.3% undervalued intrinsic discount	AN SEK 97.5author fair value 03 Junauthor updated this narrative Upcoming Store Expansion And Supply Chain Investments Will Increase Future Market Reach	PE 20x	E 14.0%	SEK 86.50

Beat the Benchmark 2026 Portfolio - Possible list

Watching

ALHC: Margin Recovery Will Drive Medicare Advantage Market Share Gains

Analysts Lift T&D Holdings Price Target as Revenue Outlook Improves Despite Lower Margins

Expanding Sleep And Rare Disease Markets Will Unlock Future Potential

Analysts are bullish with a Price Target of $174.20 based on 27.0% annual revenue growth forecasts.

ARGX: Upcoming Phase 3 Readouts and Expanded Access Will Shape Future Outlook

ADS: Stable Profit Margins Will Support Renewed Confidence Amid Legal Scrutiny

Southeastern Expansion And Merger Synergies Will Create Value

Analyst Commentary Highlights Optimism and Caution on Fifth Third Bancorp Amid Merger and Valuation Shifts

COLB: Upgraded Ratings And Peer-Leading Returns Will Drive Outperformance

Global Expansion And Regulatory Approvals Will Transform Healthcare Delivery

Urbanization And Digital Adoption Will Transform US Banking

Analysts are bullish with a Price Target of $106.25 based on 77.0% annual revenue growth forecasts.

Rising Middle Class And AI Integration Will Expand Markets

The Market Is Paying You a 9.3% Dividend and an 18.9% FCF Yield to Wait for a Recovery That's Already Starting

Long-Term Housing Undersupply And AI Underwriting Will Support Strong Future Performance

Analysts are bullish with a Price Target of HK$25.23 based on 103.3% annual revenue growth forecasts.

CS: Rising Profit Margins And Multiples Will Drive Global Expansion

US Investments And New Product Launches Will Shape Future Markets

Sector Downgrades And Digital Shifts Will Shape Near-Term Opportunities

MFC: Sector Headwinds And Mixed Performance Will Shape Near-Term Outlook

Asian Life Shift And Esure Integration Will Drive Stronger, More Resilient Earnings Ahead

Mounting Headwinds And Digital Shifts Will Suppress Future Margins

Expanding Global Oncology Markets Will Broaden Patient Access

Overvalued HBAN

Analysts are bullish with a Price Target of HK$13.97 based on 24.4% annual revenue growth forecasts.

Analysts are bullish with a Price Target of ¥4,050 based on 10.5% annual revenue growth forecasts.

Asia Pacific Expansion And Digitalization Will Fuel Sustainable Success

Analysts Highlight Cautious Optimism Amid Valuation Gains and Strategic Shifts at Rheinmetall

PNFP: Revenue Momentum And Pending Synovus Merger Will Drive Future Upside

MINISO's fair value is projected at 26.69 with an anticipated PE ratio shift of 20x

Digital Transformation And Global Wealth Transfers Will Empower Private Banking

Cosmo Pharmaceuticals Announces Strong Full Year 2024 Revenue and Cash and Provides Business and Pipeline Updates

Analysts are neutral with a Price Target of ¥2,959 based on 7.5% annual revenue growth forecasts.

MercadoLibre's 19% Revenue Growth Will Propel Their Future Success

Analysts are bullish with a Price Target of HK$101.02 based on 10.0% annual revenue growth forecasts.

Expanding Games Portfolio And New Regulated Markets Will Support Long Term Earnings Potential

Labor Shortages Will Hurt Margins Yet Spark Efficiency Gains

Hypertension And Cardiorenal Catalysts Will Reshape Long Term Prospects For This Biotech

ONC: Pivotal Oncology Trial Data Will Drive Future Upside Momentum

Yangzijiang Shipbuilding Aims for a 30% Profit Margin Boost

Sustained Sector Optimism And Major Project Wins Will Support Long-Term Expansion

Analysts are bullish with a Price Target of HK$9.06 based on 3.8% annual revenue growth forecasts.

Chinese Urbanization And Digital Transformation Will Unlock Market Potential

Analysts Lift Alamos Gold Price Target Amid Strong Growth Improved Margins and Positive Outlook

AU: Strengthening Margins And Revenue Will Drive Upward Momentum In Coming Years

Analysts are bullish with a Price Target of A$8.13 based on 65.4% annual revenue growth forecasts.

Upcoming Store Expansion And Supply Chain Investments Will Increase Future Market Reach

Watching

ALHC: Margin Recovery Will Drive Medicare Advantage Market Share Gains

Analysts Lift T&D Holdings Price Target as Revenue Outlook Improves Despite Lower Margins

Expanding Sleep And Rare Disease Markets Will Unlock Future Potential

Analysts are bullish with a Price Target of $174.20 based on 27.0% annual revenue growth forecasts.

ARGX: Upcoming Phase 3 Readouts and Expanded Access Will Shape Future Outlook

ADS: Stable Profit Margins Will Support Renewed Confidence Amid Legal Scrutiny

Southeastern Expansion And Merger Synergies Will Create Value

Analyst Commentary Highlights Optimism and Caution on Fifth Third Bancorp Amid Merger and Valuation Shifts

COLB: Upgraded Ratings And Peer-Leading Returns Will Drive Outperformance

Global Expansion And Regulatory Approvals Will Transform Healthcare Delivery

Urbanization And Digital Adoption Will Transform US Banking

Analysts are bullish with a Price Target of $106.25 based on 77.0% annual revenue growth forecasts.

Rising Middle Class And AI Integration Will Expand Markets

The Market Is Paying You a 9.3% Dividend and an 18.9% FCF Yield to Wait for a Recovery That's Already Starting

Long-Term Housing Undersupply And AI Underwriting Will Support Strong Future Performance

Analysts are bullish with a Price Target of HK$25.23 based on 103.3% annual revenue growth forecasts.

CS: Rising Profit Margins And Multiples Will Drive Global Expansion

US Investments And New Product Launches Will Shape Future Markets

Sector Downgrades And Digital Shifts Will Shape Near-Term Opportunities

MFC: Sector Headwinds And Mixed Performance Will Shape Near-Term Outlook

Asian Life Shift And Esure Integration Will Drive Stronger, More Resilient Earnings Ahead

Mounting Headwinds And Digital Shifts Will Suppress Future Margins

Expanding Global Oncology Markets Will Broaden Patient Access

Overvalued HBAN

Analysts are bullish with a Price Target of HK$13.97 based on 24.4% annual revenue growth forecasts.

Analysts are bullish with a Price Target of ¥4,050 based on 10.5% annual revenue growth forecasts.

Asia Pacific Expansion And Digitalization Will Fuel Sustainable Success

Analysts Highlight Cautious Optimism Amid Valuation Gains and Strategic Shifts at Rheinmetall

PNFP: Revenue Momentum And Pending Synovus Merger Will Drive Future Upside

MINISO's fair value is projected at 26.69 with an anticipated PE ratio shift of 20x